ArticleCancer research2018

BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.

Brandon Leonard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.